less than the two Drake’s and Lynch’s versions, the price of deleterious mutations is what drives mutation rates down (Drake 1991; Lynch 2010; Sung et al. 2012). hence, under the two products, a rise in the common expense of mutations would lead to a reduce in mutation fees. To examine this, Drake examined mutation rates of thermophiles and in